Genethon, a pioneer and leader in gene therapy for rare diseases, unveiled results at the MDA Conference in Orlando confirming the long-term efficacy of its GNT0004 gene therapy in Duchenne muscular ...
Do you think you're going to be the one dumb, ugly, tired person?' Inside a San Francisco startup's quest for peptide ...
Logan Graham, the leader of the red team, recalled the bioweapons scare as an example of the challenges Anthropic faces at a ...
Custom-fitted oral appliances reduce airway obstruction by physically repositioning the lower jaw or tongue forward during ...
Walking into an emergency room is a bit like stepping onto a stage where anything can happen, except the actors don’t always ...
Having such an amazing archive of material, from the Just One Thing podcast to his many TV programmes, felt like a blessing ...
Jacobin on MSN
Thermonuclear slop and the return of the bomb
There are so many low-quality, kitsch-militarist, cringe aspects to the past several weeks’ bumble toward an AI-enabled, nuclear-curious World War III — or at least some vast, multi-theater, ...
With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients ...
- Transformative year for tau in AD: VY1706 clinical entry and VY7523 clinical data anticipated H2 2026 - - Validating brain-targeted capsids in humans: expect two I.V.-delivered neuro gene therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results